Status:

TERMINATED

Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty

Lead Sponsor:

Teikoku Pharma USA, Inc.

Conditions:

Pain, Postoperative

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The primary objective of this study is to evaluate the analgesic efficacy of DMTS, compared with placebo, in subjects following abdominoplasty.

Detailed Description

This is a randomized, double-blind, placebo-controlled, one-time application study of DMTS or matching placebo over a 4-day treatment period (Day 1 Time 0 occurs when the DMTS or matching placebo syst...

Eligibility Criteria

Inclusion

  • Male or female, ≥ 18 years of age.
  • Scheduled to undergo a full abdominoplasty (including repair of small incidental abdominal hernias, but not including liposuction).
  • Have a physical status classification of 1 or 2 per the American Society of Anesthesiology.
  • Have a body weight \> 58 kg, and body mass index of 20 to 38 kg/m2, inclusive.

Exclusion

  • Known sensitivity to dexmedetomidine or any excipient in the DMTS/placebo or to any peri- or postoperative medication whose use is required in this study.
  • Skin abnormality (eg, scar, tattoo) or unhealthy skin condition (eg, burns, wounds) at the DMTS/matching placebo application site, according to examination by the investigator at screening or admission to the clinic prior to surgery.
  • History of deep vein thrombosis or factor V Leiden deficiency.
  • History of syncope or other syncopal attacks.
  • Present and/or significant history of postural hypotension (determined through examination by the investigator or designee), or history of severe dizziness or fainting on standing in the opinion of the investigator.
  • Evidence of a clinically significant 12-lead ECG abnormality.

Key Trial Info

Start Date :

July 7 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 19 2023

Estimated Enrollment :

179 Patients enrolled

Trial Details

Trial ID

NCT05412992

Start Date

July 7 2022

End Date

April 19 2023

Last Update

December 24 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Anaheim Clinical Trials, LLC

Anaheim, California, United States, 92801

2

JBR Clinical Research

Salt Lake City, Utah, United States, 84107